nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2D6—Vinorelbine—ovarian cancer	0.103	0.213	CbGbCtD
Dolasetron—CYP3A4—Topotecan—ovarian cancer	0.0926	0.192	CbGbCtD
Dolasetron—CYP2C9—Paclitaxel—ovarian cancer	0.0788	0.164	CbGbCtD
Dolasetron—CYP3A4—Vinorelbine—ovarian cancer	0.0652	0.135	CbGbCtD
Dolasetron—CYP3A4—Paclitaxel—ovarian cancer	0.0458	0.0951	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—ovarian cancer	0.0388	0.0806	CbGbCtD
Dolasetron—CYP3A4—Docetaxel—ovarian cancer	0.0331	0.0688	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—ovarian cancer	0.0247	0.0513	CbGbCtD
Dolasetron—Angioedema—Paclitaxel—ovarian cancer	0.000664	0.00128	CcSEcCtD
Dolasetron—Purpura—Doxorubicin—ovarian cancer	0.000662	0.00128	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00066	0.00127	CcSEcCtD
Dolasetron—Flushing—Docetaxel—ovarian cancer	0.000657	0.00127	CcSEcCtD
Dolasetron—Cardiac arrest—Epirubicin—ovarian cancer	0.000656	0.00127	CcSEcCtD
Dolasetron—Malaise—Paclitaxel—ovarian cancer	0.000655	0.00126	CcSEcCtD
Dolasetron—Vertigo—Paclitaxel—ovarian cancer	0.000653	0.00126	CcSEcCtD
Dolasetron—Syncope—Paclitaxel—ovarian cancer	0.000652	0.00126	CcSEcCtD
Dolasetron—Rash—Topotecan—ovarian cancer	0.00065	0.00125	CcSEcCtD
Dolasetron—Hypersensitivity—Vinorelbine—ovarian cancer	0.00065	0.00125	CcSEcCtD
Dolasetron—Dermatitis—Topotecan—ovarian cancer	0.000649	0.00125	CcSEcCtD
Dolasetron—Ataxia—Epirubicin—ovarian cancer	0.000649	0.00125	CcSEcCtD
Dolasetron—Headache—Topotecan—ovarian cancer	0.000646	0.00125	CcSEcCtD
Dolasetron—Palpitations—Paclitaxel—ovarian cancer	0.000642	0.00124	CcSEcCtD
Dolasetron—Dehydration—Epirubicin—ovarian cancer	0.000642	0.00124	CcSEcCtD
Dolasetron—Loss of consciousness—Paclitaxel—ovarian cancer	0.000639	0.00123	CcSEcCtD
Dolasetron—Rash—Melphalan—ovarian cancer	0.000637	0.00123	CcSEcCtD
Dolasetron—Dermatitis—Melphalan—ovarian cancer	0.000636	0.00123	CcSEcCtD
Dolasetron—Chills—Docetaxel—ovarian cancer	0.000635	0.00122	CcSEcCtD
Dolasetron—Cough—Paclitaxel—ovarian cancer	0.000634	0.00122	CcSEcCtD
Dolasetron—Asthenia—Vinorelbine—ovarian cancer	0.000633	0.00122	CcSEcCtD
Dolasetron—Arrhythmia—Docetaxel—ovarian cancer	0.000632	0.00122	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00063	0.00122	CcSEcCtD
Dolasetron—Convulsion—Paclitaxel—ovarian cancer	0.00063	0.00121	CcSEcCtD
Dolasetron—Hypertension—Paclitaxel—ovarian cancer	0.000628	0.00121	CcSEcCtD
Dolasetron—Pruritus—Vinorelbine—ovarian cancer	0.000624	0.0012	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000621	0.0012	CcSEcCtD
Dolasetron—Myalgia—Paclitaxel—ovarian cancer	0.000619	0.00119	CcSEcCtD
Dolasetron—Chest pain—Paclitaxel—ovarian cancer	0.000619	0.00119	CcSEcCtD
Dolasetron—Arthralgia—Paclitaxel—ovarian cancer	0.000619	0.00119	CcSEcCtD
Dolasetron—Anxiety—Paclitaxel—ovarian cancer	0.000617	0.00119	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—ovarian cancer	0.000616	0.00119	CcSEcCtD
Dolasetron—Discomfort—Paclitaxel—ovarian cancer	0.000611	0.00118	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000609	0.00117	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—ovarian cancer	0.000607	0.00117	CcSEcCtD
Dolasetron—Dry mouth—Paclitaxel—ovarian cancer	0.000605	0.00117	CcSEcCtD
Dolasetron—Diarrhoea—Vinorelbine—ovarian cancer	0.000603	0.00116	CcSEcCtD
Dolasetron—Dysgeusia—Docetaxel—ovarian cancer	0.000603	0.00116	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—ovarian cancer	0.0006	0.00116	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—ovarian cancer	0.0006	0.00116	CcSEcCtD
Dolasetron—Confusional state—Paclitaxel—ovarian cancer	0.000598	0.00115	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—ovarian cancer	0.000594	0.00115	CcSEcCtD
Dolasetron—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000593	0.00114	CcSEcCtD
Dolasetron—Oedema—Paclitaxel—ovarian cancer	0.000593	0.00114	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—ovarian cancer	0.000585	0.00113	CcSEcCtD
Dolasetron—Shock—Paclitaxel—ovarian cancer	0.000584	0.00113	CcSEcCtD
Dolasetron—Dizziness—Vinorelbine—ovarian cancer	0.000583	0.00113	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000583	0.00112	CcSEcCtD
Dolasetron—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000581	0.00112	CcSEcCtD
Dolasetron—Tachycardia—Paclitaxel—ovarian cancer	0.000579	0.00112	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000575	0.00111	CcSEcCtD
Dolasetron—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000573	0.00111	CcSEcCtD
Dolasetron—Anaemia—Docetaxel—ovarian cancer	0.000569	0.0011	CcSEcCtD
Dolasetron—Anorexia—Paclitaxel—ovarian cancer	0.000565	0.00109	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000563	0.00109	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—ovarian cancer	0.000558	0.00108	CcSEcCtD
Dolasetron—Rash—Vinorelbine—ovarian cancer	0.000556	0.00107	CcSEcCtD
Dolasetron—Dermatitis—Vinorelbine—ovarian cancer	0.000556	0.00107	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—ovarian cancer	0.000556	0.00107	CcSEcCtD
Dolasetron—Hypotension—Paclitaxel—ovarian cancer	0.000554	0.00107	CcSEcCtD
Dolasetron—Headache—Vinorelbine—ovarian cancer	0.000553	0.00107	CcSEcCtD
Dolasetron—Syncope—Docetaxel—ovarian cancer	0.000553	0.00107	CcSEcCtD
Dolasetron—Palpitations—Docetaxel—ovarian cancer	0.000544	0.00105	CcSEcCtD
Dolasetron—Loss of consciousness—Docetaxel—ovarian cancer	0.000542	0.00104	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—ovarian cancer	0.000541	0.00104	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00054	0.00104	CcSEcCtD
Dolasetron—Cough—Docetaxel—ovarian cancer	0.000538	0.00104	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—ovarian cancer	0.000535	0.00103	CcSEcCtD
Dolasetron—Convulsion—Docetaxel—ovarian cancer	0.000534	0.00103	CcSEcCtD
Dolasetron—Paraesthesia—Paclitaxel—ovarian cancer	0.000533	0.00103	CcSEcCtD
Dolasetron—Hypertension—Docetaxel—ovarian cancer	0.000532	0.00103	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—ovarian cancer	0.000532	0.00103	CcSEcCtD
Dolasetron—Dyspnoea—Paclitaxel—ovarian cancer	0.000529	0.00102	CcSEcCtD
Dolasetron—Somnolence—Paclitaxel—ovarian cancer	0.000527	0.00102	CcSEcCtD
Dolasetron—Chest pain—Docetaxel—ovarian cancer	0.000525	0.00101	CcSEcCtD
Dolasetron—Myalgia—Docetaxel—ovarian cancer	0.000525	0.00101	CcSEcCtD
Dolasetron—Arthralgia—Docetaxel—ovarian cancer	0.000525	0.00101	CcSEcCtD
Dolasetron—Dyspepsia—Paclitaxel—ovarian cancer	0.000522	0.00101	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—ovarian cancer	0.000518	0.001	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—ovarian cancer	0.000518	0.001	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—ovarian cancer	0.000516	0.000995	CcSEcCtD
Dolasetron—Decreased appetite—Paclitaxel—ovarian cancer	0.000516	0.000995	CcSEcCtD
Dolasetron—Dry mouth—Docetaxel—ovarian cancer	0.000513	0.00099	CcSEcCtD
Dolasetron—Fatigue—Paclitaxel—ovarian cancer	0.000511	0.000987	CcSEcCtD
Dolasetron—Pain—Paclitaxel—ovarian cancer	0.000507	0.000979	CcSEcCtD
Dolasetron—Constipation—Paclitaxel—ovarian cancer	0.000507	0.000979	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—ovarian cancer	0.000507	0.000978	CcSEcCtD
Dolasetron—Confusional state—Docetaxel—ovarian cancer	0.000507	0.000978	CcSEcCtD
Dolasetron—Anaphylactic shock—Docetaxel—ovarian cancer	0.000503	0.00097	CcSEcCtD
Dolasetron—Oedema—Docetaxel—ovarian cancer	0.000503	0.00097	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—ovarian cancer	0.000502	0.000968	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—ovarian cancer	0.000495	0.000955	CcSEcCtD
Dolasetron—Shock—Docetaxel—ovarian cancer	0.000495	0.000954	CcSEcCtD
Dolasetron—Thrombocytopenia—Docetaxel—ovarian cancer	0.000492	0.00095	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—ovarian cancer	0.000492	0.000949	CcSEcCtD
Dolasetron—Tachycardia—Docetaxel—ovarian cancer	0.000491	0.000947	CcSEcCtD
Dolasetron—Feeling abnormal—Paclitaxel—ovarian cancer	0.000489	0.000943	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—ovarian cancer	0.000486	0.000937	CcSEcCtD
Dolasetron—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000485	0.000936	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—ovarian cancer	0.00048	0.000925	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—ovarian cancer	0.00048	0.000925	CcSEcCtD
Dolasetron—Anorexia—Docetaxel—ovarian cancer	0.000479	0.000925	CcSEcCtD
Dolasetron—Urticaria—Paclitaxel—ovarian cancer	0.000471	0.000909	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—ovarian cancer	0.00047	0.000907	CcSEcCtD
Dolasetron—Hypotension—Docetaxel—ovarian cancer	0.00047	0.000906	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—ovarian cancer	0.000469	0.000905	CcSEcCtD
Dolasetron—Abdominal pain—Paclitaxel—ovarian cancer	0.000469	0.000905	CcSEcCtD
Dolasetron—Body temperature increased—Paclitaxel—ovarian cancer	0.000469	0.000905	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—ovarian cancer	0.000464	0.000895	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—ovarian cancer	0.00046	0.000887	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000458	0.000884	CcSEcCtD
Dolasetron—Paraesthesia—Docetaxel—ovarian cancer	0.000452	0.000871	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—ovarian cancer	0.00045	0.000867	CcSEcCtD
Dolasetron—Dyspnoea—Docetaxel—ovarian cancer	0.000448	0.000865	CcSEcCtD
Dolasetron—Somnolence—Docetaxel—ovarian cancer	0.000447	0.000862	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—ovarian cancer	0.000445	0.000859	CcSEcCtD
Dolasetron—Flushing—Epirubicin—ovarian cancer	0.000443	0.000855	CcSEcCtD
Dolasetron—Dyspepsia—Docetaxel—ovarian cancer	0.000443	0.000854	CcSEcCtD
Dolasetron—Decreased appetite—Docetaxel—ovarian cancer	0.000437	0.000843	CcSEcCtD
Dolasetron—Hypersensitivity—Paclitaxel—ovarian cancer	0.000437	0.000843	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—ovarian cancer	0.000435	0.000839	CcSEcCtD
Dolasetron—Fatigue—Docetaxel—ovarian cancer	0.000434	0.000836	CcSEcCtD
Dolasetron—Pain—Docetaxel—ovarian cancer	0.00043	0.000829	CcSEcCtD
Dolasetron—Constipation—Docetaxel—ovarian cancer	0.00043	0.000829	CcSEcCtD
Dolasetron—Chills—Epirubicin—ovarian cancer	0.000428	0.000826	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—ovarian cancer	0.000426	0.000823	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—ovarian cancer	0.000426	0.000821	CcSEcCtD
Dolasetron—Asthenia—Paclitaxel—ovarian cancer	0.000426	0.000821	CcSEcCtD
Dolasetron—Pruritus—Paclitaxel—ovarian cancer	0.00042	0.00081	CcSEcCtD
Dolasetron—Feeling abnormal—Docetaxel—ovarian cancer	0.000414	0.000799	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—ovarian cancer	0.000412	0.000794	CcSEcCtD
Dolasetron—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000411	0.000793	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—ovarian cancer	0.00041	0.000791	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—ovarian cancer	0.000409	0.00079	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—ovarian cancer	0.000407	0.000785	CcSEcCtD
Dolasetron—Diarrhoea—Paclitaxel—ovarian cancer	0.000406	0.000783	CcSEcCtD
Dolasetron—Abdominal pain—Docetaxel—ovarian cancer	0.000397	0.000767	CcSEcCtD
Dolasetron—Body temperature increased—Docetaxel—ovarian cancer	0.000397	0.000767	CcSEcCtD
Dolasetron—Chills—Doxorubicin—ovarian cancer	0.000396	0.000764	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—ovarian cancer	0.000395	0.000761	CcSEcCtD
Dolasetron—Dizziness—Paclitaxel—ovarian cancer	0.000392	0.000757	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—ovarian cancer	0.000386	0.000744	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—ovarian cancer	0.000384	0.000741	CcSEcCtD
Dolasetron—Agitation—Epirubicin—ovarian cancer	0.000382	0.000737	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—ovarian cancer	0.000379	0.000731	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—ovarian cancer	0.000377	0.000726	CcSEcCtD
Dolasetron—Malaise—Epirubicin—ovarian cancer	0.000375	0.000723	CcSEcCtD
Dolasetron—Rash—Paclitaxel—ovarian cancer	0.000374	0.000722	CcSEcCtD
Dolasetron—Dermatitis—Paclitaxel—ovarian cancer	0.000374	0.000721	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—ovarian cancer	0.000373	0.00072	CcSEcCtD
Dolasetron—Syncope—Epirubicin—ovarian cancer	0.000373	0.000719	CcSEcCtD
Dolasetron—Headache—Paclitaxel—ovarian cancer	0.000372	0.000717	CcSEcCtD
Dolasetron—Hypersensitivity—Docetaxel—ovarian cancer	0.00037	0.000715	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—ovarian cancer	0.000367	0.000708	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—ovarian cancer	0.000365	0.000705	CcSEcCtD
Dolasetron—Cough—Epirubicin—ovarian cancer	0.000363	0.000699	CcSEcCtD
Dolasetron—Asthenia—Docetaxel—ovarian cancer	0.000361	0.000696	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—ovarian cancer	0.00036	0.000695	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—ovarian cancer	0.000359	0.000692	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000357	0.000688	CcSEcCtD
Dolasetron—Pruritus—Docetaxel—ovarian cancer	0.000356	0.000686	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—ovarian cancer	0.000355	0.000686	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—ovarian cancer	0.000354	0.000682	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—ovarian cancer	0.000354	0.000682	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—ovarian cancer	0.000354	0.000682	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—ovarian cancer	0.000353	0.000682	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—ovarian cancer	0.000353	0.00068	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—ovarian cancer	0.00035	0.000674	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—ovarian cancer	0.000347	0.000669	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—ovarian cancer	0.000346	0.000667	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—ovarian cancer	0.000345	0.000666	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—ovarian cancer	0.000345	0.000665	CcSEcCtD
Dolasetron—Diarrhoea—Docetaxel—ovarian cancer	0.000344	0.000664	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—ovarian cancer	0.000342	0.00066	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—ovarian cancer	0.00034	0.000655	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—ovarian cancer	0.000339	0.000654	CcSEcCtD
Dolasetron—Oedema—Epirubicin—ovarian cancer	0.000339	0.000654	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—ovarian cancer	0.000338	0.000652	CcSEcCtD
Dolasetron—Cough—Doxorubicin—ovarian cancer	0.000336	0.000647	CcSEcCtD
Dolasetron—Shock—Epirubicin—ovarian cancer	0.000334	0.000644	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—ovarian cancer	0.000333	0.000643	CcSEcCtD
Dolasetron—Dizziness—Docetaxel—ovarian cancer	0.000333	0.000641	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—ovarian cancer	0.000332	0.000641	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—ovarian cancer	0.000332	0.00064	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—ovarian cancer	0.000331	0.000638	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—ovarian cancer	0.000328	0.000632	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—ovarian cancer	0.000327	0.000631	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—ovarian cancer	0.000327	0.000631	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—ovarian cancer	0.000327	0.000631	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—ovarian cancer	0.000326	0.000629	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—ovarian cancer	0.000323	0.000624	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—ovarian cancer	0.000323	0.000624	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—ovarian cancer	0.00032	0.000618	CcSEcCtD
Dolasetron—Rash—Docetaxel—ovarian cancer	0.000317	0.000612	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—ovarian cancer	0.000317	0.000611	CcSEcCtD
Dolasetron—Dermatitis—Docetaxel—ovarian cancer	0.000317	0.000611	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—ovarian cancer	0.000316	0.00061	CcSEcCtD
Dolasetron—Headache—Docetaxel—ovarian cancer	0.000315	0.000608	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—ovarian cancer	0.000314	0.000605	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000314	0.000605	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000309	0.000596	CcSEcCtD
Dolasetron—Shock—Doxorubicin—ovarian cancer	0.000309	0.000596	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000307	0.000593	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—ovarian cancer	0.000306	0.000591	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—ovarian cancer	0.000305	0.000587	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000303	0.000585	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—ovarian cancer	0.000302	0.000583	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—ovarian cancer	0.000302	0.000582	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—ovarian cancer	0.000299	0.000577	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—ovarian cancer	0.000299	0.000576	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—ovarian cancer	0.000295	0.000569	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—ovarian cancer	0.000293	0.000566	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—ovarian cancer	0.000292	0.000564	CcSEcCtD
Dolasetron—Constipation—Epirubicin—ovarian cancer	0.00029	0.000559	CcSEcCtD
Dolasetron—Pain—Epirubicin—ovarian cancer	0.00029	0.000559	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000286	0.000551	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—ovarian cancer	0.000282	0.000544	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—ovarian cancer	0.00028	0.00054	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—ovarian cancer	0.000279	0.000539	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—ovarian cancer	0.000279	0.000538	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000277	0.000535	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—ovarian cancer	0.000276	0.000533	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—ovarian cancer	0.000273	0.000526	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—ovarian cancer	0.000271	0.000522	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—ovarian cancer	0.000269	0.00052	CcSEcCtD
Dolasetron—Pain—Doxorubicin—ovarian cancer	0.000268	0.000518	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—ovarian cancer	0.000268	0.000518	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—ovarian cancer	0.000268	0.000517	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—ovarian cancer	0.000268	0.000517	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—ovarian cancer	0.000259	0.000499	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000257	0.000495	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—ovarian cancer	0.00025	0.000482	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—ovarian cancer	0.000249	0.000481	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—ovarian cancer	0.000248	0.000479	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—ovarian cancer	0.000248	0.000479	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—ovarian cancer	0.000243	0.000469	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—ovarian cancer	0.00024	0.000463	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—ovarian cancer	0.000232	0.000448	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—ovarian cancer	0.000231	0.000446	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—ovarian cancer	0.000225	0.000434	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—ovarian cancer	0.000224	0.000433	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—ovarian cancer	0.000222	0.000428	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—ovarian cancer	0.000215	0.000414	CcSEcCtD
Dolasetron—Rash—Epirubicin—ovarian cancer	0.000214	0.000412	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—ovarian cancer	0.000214	0.000412	CcSEcCtD
Dolasetron—Headache—Epirubicin—ovarian cancer	0.000212	0.00041	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—ovarian cancer	0.000208	0.0004	CcSEcCtD
Dolasetron—Rash—Doxorubicin—ovarian cancer	0.000198	0.000382	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—ovarian cancer	0.000198	0.000381	CcSEcCtD
Dolasetron—Headache—Doxorubicin—ovarian cancer	0.000197	0.000379	CcSEcCtD
